Silylated biomolecules

US9285360B2 · kind B2 · utility

Assignees

• Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
• UNIVERSITE DE NANTES · FR
• CHU NANTES · FR
• Institut Francais de Recherche Pour l'Exploitation de la Mer (IFREMER) · FR

Inventors

• Pierre Weiss · Nantes, FR
• Jérôme Guicheux · Nantes, FR
• Gildas Rethore · Nantes, FR
• Emile Rederstorff · Nantes, FR
• Samia Laib · Nantes, FR

Key dates

• Filing date: Jan 25, 2011
• Grant date: Mar 15, 2016
• Expiry date: Jul 25, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C08L2203/02
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention concerns: —a silylated biomolecule having the following formula (I): —the process for the preparation of a silylated biomolecule of formula (I), —the use of a silylated biomolecule of formula (I) to functionalize the surface of a support, —a process for the preparation of a hydrogel by use of a silylated biomolecule of formula (I), the hydrogel obtainable by said process, —said hydrogel as a biological tissue substitute, —a composition comprising said hydrogel in a pharmaceutically acceptable vehicle, —said composition for the release of active principle.